In agreement with liver steatosis, serum triglycerides decreased in both the KHK siRNA and inhibitor groups (Supplemental Figure 2A), while serum cholesterol, which in mice mainly consists of HDL-cholesterol, was increased only in the inhibitor-treated mice (Supplemental Figure 2B). Here, KHK is linked to fatty liver disease.